Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lopinavir/Ritonavir and Rifampin in HIV/TB Co-infection
NCT00771498Phase 4Completed
- Sponsor
- Fundação Oswaldo Cruz
- Start
- Nov 2008
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label trial of lopinavir and ritonavir in human immunodeficiency virus infection (HIV), sponsored by Fundação Oswaldo Cruz. Started Nov 2008; status: completed.
02
Drugs
lopinavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00771498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00771498.